Catalent
CTLT
#1588
Rank
โ‚ฌ10.33 B
Marketcap
56,93ย โ‚ฌ
Share price
1.12%
Change (1 day)
56.03%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Net assets

Net assets on the balance sheet as of September 2024 : โ‚ฌ3.38 Billion

According to Catalent's latest financial reports the company has โ‚ฌ3.38 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Catalent - Net assets on balance sheet (from 2013 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$โ‚ฌ4.24 B-7.18%
2022-06-30$โ‚ฌ4.57 B27.29%
2021-06-30$โ‚ฌ3.59 B15.2%
2020-06-30$โ‚ฌ3.11 B55.16%
2019-06-30$โ‚ฌ2.00 B116.37%
2018-06-30$โ‚ฌ0.92 B46.84%
2017-06-30$โ‚ฌ0.63 B10.66%
2016-06-30$โ‚ฌ0.57 B1.16%
2015-06-30$โ‚ฌ0.56 B-307.31%
2014-06-30$-โ‚ฌ0.28 Billion-13.6%
2013-06-30$-โ‚ฌ0.32 Billion13.83%
2012-06-30$-โ‚ฌ0.28 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚ฌ0.96 B-71.57%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.16 Billion-104.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.98 B 17.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ68.56 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA